American International Group, Inc. Acelrx Pharmaceuticals Inc Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.03 - $1.7 $60,267 - $99,470	-58,512 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.25 - $2.77 $14,992 - $33,223	11,994 Added 25.78%	58,512 $99,000
Q4 2020 Feb 12, 2021	SELL	$1.18 - $1.98 $1,576 - $2,645	-1,336 Reduced 2.79%	46,518 $58,000
Q3 2020 Nov 04, 2020	SELL	$1.01 - $1.81 $1,098 - $1,969	-1,088 Reduced 2.22%	47,854 $68,000
Q2 2020 Aug 12, 2020	BUY	$1.03 - $1.69 $2,633 - $4,321	2,557 Added 5.51%	48,942 $59,000
Q1 2020 May 04, 2020	SELL	$0.76 - $2.07 $2,038 - $5,551	-2,682 Reduced 5.47%	46,385 $55,000
Q4 2019 Feb 05, 2020	SELL	$1.66 - $2.4 $685 - $991	-413 Reduced 0.83%	49,067 $104,000
Q3 2019 Nov 08, 2019	SELL	$2.1 - $2.87 $722 - $987	-344 Reduced 0.69%	49,480 $109,000
Q2 2019 Aug 13, 2019	BUY	$2.1 - $3.93 $104,630 - $195,808	49,824 New	49,824 $127,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.